EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Success of the German Cystic Fibrosis Registry

Lutz Naehrlich iD, Manuel Burkhart, Registry Working Group of the German CF Registry

Pharmacoepidemiology and Drug Safety · 2025

DOI: 10.1002/pds.70076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Lutz Naehrlich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Justus-Liebig-University, Giessen, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Registries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The German Cystic Fibrosis (CF) Registry (GCFR) is a national General Data Protection Regulation–compliant centralised database sponsored by the German Cystic Fibrosis Association (Mukoviszidose e.V.) and based on informed consent for each participating patient, ethical approval, and data protection votes. The aims of the GCFR are to optimise quality of care for CF at the centres, generate epidemiologic overviews, address research questions related to improved CF care, and inform caregivers, patients (aimed at patient empowerment), and health authorities and industry (aimed at care planning and pharmacovigilance). Established in 1995, the Registry has captured data on > 9600 individuals with a combined total of more than 140 000 annual assessments with an estimated coverage rate of > 90%. Patient data are collected after informed consent and confirmed diagnosis of CF, or a CFTR‐related disorder, or a screening‐positive inconclusive diagnosis of CF (i.e., CFSPID). The registry collects core, encounter, and annual health data. Data include demographics, anthropometrics, lung function, microbiology, CF‐specific complications and chronic medications, hospitalisations, demand‐oriented antibiotic therapies, and outcomes (death and transplants). Real world and pharmacovigilance studies have been published and additional research underway; there is a formal process for requesting access to the GCFR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisRegistriesHumansGermanyDatabases, FactualPharmacovigilance

Autor:innen und Institutionen

  • Department of Pediatrics, Justus-Liebig-University, Giessen, Germany.
  • Mukoviszidose Institut gGmbH, Bonn, Germany.

ORCID-Profile: Lutz Naehrlich

Zitieren

APA

Naehrlich, L., Burkhart, M., & Registry Working Group of the German CF Registry (2025). Success of the German Cystic Fibrosis Registry. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70076

Vancouver

Naehrlich L, Burkhart M, Registry Working Group of the German CF Registry. Success of the German Cystic Fibrosis Registry. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70076

BibTeX
@article{Naehrlich2025,
  author = {Naehrlich, Lutz and Burkhart, Manuel and Registry Working Group of the German CF Registry, Registry Working Group of the German CF Registry},
  title = {Success of the German Cystic Fibrosis Registry},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2025},
  doi = {10.1002/pds.70076}
}
Kostenlos starten →